Healthmed Services Ltd. announced that the company's business plan is to expand its portfolio of products beyond organ transplantation, to include promising new technologies that can be commercialized within a fairly short period of time. In the field of Diabetes Testing the company has developed a saliva test for monitoring glucose control in diabetes. Diabetics will be able to mail a saliva sample to a laboratory that will perform the test and record the result. Patients will be able to access their results in private using the Internet. The acquisition and merger of Diabetes Reference Services in 2011 gave the company the enabling technologies to monitor glucose control in Type 2 diabetics in a non-invasive manner by testing saliva samples. This technology represents an important component of any diabetes prevention program. The medical profession cannot ignore that there is a diabetes epidemic occurring throughout the world and the medical and economic effects will be catastrophic if it is not recognized. However, with timely testing, counseling and simple life-style changes such as dieting and exercise, the onset of diabetes can be mitigated or prevented. The routine saliva testing under development by HealthMed Services to monitor glucose control is simple, convenient and painless, and it believes this will encourage compliance with all diabetes prevention programs.